my esteemed stocktwits colleague advised me that I sold my $FOLD 2 soon. will prolly buy tomorrow. If I lose, I will blame him. $BLUE another fallen knife; that's another stock for tomorrow Goldman Sachs analyst Salveen Richter lowered the price target on bluebird bio (NASDAQ: BLUE) to $67.00 (from $146.00) while maintaining a Buy rating. and, finally $EPHE I couldn't buy at 30.97 for several hours on 2/18. gave up and moved on. It ended at 30.93 and traded as low as 30.85 in the last hour.